Biotech Archives - Page 24 of 795

2 minute read

What’s Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

May 24, 8:45 AM

Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant ovarian cancer is underway.

AMGN

2 minute read

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

By Vandana Singh

May 23, 2:30 PM

Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's commercialization and cardiovascular pipeline expansion.

CYTK

2 minute read

Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies

By Vandana Singh

May 23, 2:00 PM

U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medical equipment companies accused of supporting terrorism in Iraq.

AZN

2 minute read

Pfizer’s Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions

By Surbhi Jain

May 23, 1:36 PM

Pfizer launched a $1.5 billion cost reduction program to enhance operational efficiencies and cut costs amid declining sales. Stock shows bullish momentum.

PFE

1 minute read

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity

By Vandana Singh

May 23, 12:53 PM

Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later this year.

AZN

2 minute read

Johnson & Johnson’s Bankruptcy Tactics Are Fraudulent, Plaintiffs Accuse Company Of Defrauding Cancer Victims

By Vandana Singh

May 23, 11:26 AM

Cancer victims have filed a lawsuit against Johnson & Johnson, accusing the company of fraudulently using a shell company's bankruptcy to evade lawsuits. The plaintiffs claim the "Texas two-step" maneuver was designed to protect J&J's assets from litigation.

JNJ

1 minute read

Lexaria Awards Contract To A CRO To Perform The Co’s Human Pilot Study #3, Which Will Evaluate A Dual Action GLP-1 + GIP

By Benzinga Newsdesk

May 23, 10:56 AM

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or

LEXX

2 minute read

Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027

By Benzinga Neuro

May 23, 7:31 AM

The company disclosed the new program in a filing with the Securities and Exchange Commission.

PFE

1 minute read

Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb

By Erica Kollmann

May 22, 2:43 PM

Experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of Covid infections in the U.S. and experts believe its mutations have made the variant more immune evasive.

BNTX

2 minute read

Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M

By Vandana Singh

May 22, 1:25 PM

A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous $834 million judgment

BMY